Concentration of maternal BICOID (BCD) establishes the anterior pattern in the Drosophila embryo. Successive deletions in the bcd promoter allowed us to localize an enhancer sequence in the 5′-UTR and a down-regulating element downstream of the ATG initiator codon, and identify a 49 bp region sufficient to drive transcription of a reporter gene specifically in nurse cells. This fragment contains two binding sites for the Serendipity (Sry) d zinc finger activator, that mediate its cooperative binding. Both sites (sdbs) are essential for bcd expression. Further analysis showed that the bcd promoter configuration is decisive for Sry d activating function. Replacement of sdbs by binding sites for Sry b, the Sry d paralog, restores bcd transcription in sry d mutant ovaries, demonstrating that the functional divergence between these two proteins during evolution was mainly driven by changes in their DNA-specific recognition properties, resulting in the control of separate developmental pathways.
Introduction
Elaboration of the body plan in the head and thoracic regions of the Drosophila embryo is largely controlled by the activity of the maternal morphogen bicoid (bcd) (Frohnhöfer and Nüsslein-Volhard, 1986; Nüsslein-Volhard et al., 1987 ; review by Driever, 1993) . bcd mRNA transcribed by nurse-cells in the egg chamber is transported to the oocyte where it remains localized at the anterior pole (St Johnston et al., 1989) . The localized bcd RNA is translated after fertilization to give a concentration gradient of protein along the antero-posterior axis of the embryo that peaks at the anterior pole (Driever and Nüsslein-Volhard, 1988a) . Bicoid is a transcription regulator that acts as a morphogen by eliciting distinct transcriptional responses from its several targets at different concentrations (Tautz, 1988; Driever and Nüsslein-Volhard, 1989; Struhl et al., 1989 ; review by Driever, 1993) . In addition, Bicoid is thought to block translation of a posterior determinant caudal, even at low concentration (Dubnau and Struhl, 1996, Rivero-Pomar et al., 1996) . Thus, one key feature of BCD is its concentration dependent action. The observation that the concentration of Bcd protein was roughly proportional to the number of bcd gene copies strongly argued for a control of the level of bcd activity at the transcriptional level (Driever and Nüsslein-Volhard, 1988b; Struhl et al., 1989 ). Yet, whereas genetic screens for maternal-effect mutations identified factors involved in bcd mRNA localization, they failed to uncover mutations affecting bcd transcription. One possible explanation was that several different activators with, at least partly, redundant functions were involved, whose mutations would only lower but not abolish bcd transcription. One difficulty in identifying such 'hypomorphic' mutations is the plasticity in the embryonic development of Drosophila: embryos laid by mothers with either a single or up to five, rather than the normal two, copies of bcd, although showing initial distortions in the expression of the zygotic segmentation genes and the position and size of mitotic domains, develop into relatively normal larvae and adults (Frohnhöfer and Nüsslein-Volhard, 1986; Namba et al., 1997) . One other possible reason was that only transcription factors with earlier requirements during fly development were involved for bcd transcription, precluding their identification in screens for maternal-effect mutations.
Supporting this second possibility, we previously reported that the Serendipity delta (Sry d) C2H2 zinc finger protein is a direct activator of bcd transcription (Payre et al., 1994) . sry d is a zygotic lethal gene whose mutation results in pleiotropic somatic and germ-line defects, the relative severity of which depends upon the allele considered (Crozatier et al., 1992; and unpublished data) . sry d and its close paralog, sry b, provide an interesting paradigm for studies of functional aspects of the modular structure of C2H2 zinc finger proteins (Ferrer et al., 1994) . While a single copy of wild-type sry d fully suppresses the sry d mutant lethality and sterility, increasing the copy number of sry b does not rescue any of these phenotypes including the lack of bcd expression (Crozatier et al., 1992; Payre et al., 1994) .
The specific requirement of Sry d for bcd expression, an unexpected link between a zygotic factor with pleiotropic functions and the establishment of coordinates of the Drosophila egg, led us to investigate in detail the Sry d/bcd interaction. In this paper, we show that a 49 bp bcd DNA fragment including two Sry d binding sites and the 5′-most bcd transcription starts is sufficient to mimic bcd expression in ovaries. We then show that each of the two Sry d binding sites is essential for bcd transcription and that the bcd promoter configuration potentiates the ability of Sry d to activate bcd transcription specifically in nurse cells. Finally, we show that a bcd transgene where the two Sry d binding sites have been replaced by consensus recognition sites for Sry b (Payre and Vincent, 1991) , is transcribed in Sry d mutant ovaries. These results strongly suggest that the main determinant of the functional difference between the Sry b and Sry d paralog zinc finger proteins resides in their DNA recognition properties, a co-evolution of these proteins and their target binding sites having resulted in the regulation of distinct sets of genes.
Results

A 49 bp bcd DNA fragment drives nurse cell-specific transcription of a reporter gene
In order to define the 5′ and 3′ limits of the functional bcd promoter, we made a series of constructs fusing bcd genomic fragments to the lacZ reporter gene and analyzed their expression in transformant lines (Fig. 1) . Several independent lines were assayed for each construct and LacZ expression examined in embryos, third-instar larvae, whole male and female adults, and dissected ovaries and testis. The reference construct, Kex2-Z (Fig. 1a) , included 2732 bp of DNA upstream of the 5′-most bcd transcription start site (Seeger and Kaufman, 1990) . It also included 923 bp of transcribed DNA corresponding to the entire first exon and intron plus 13 bp of the second exon. With this construct, LacZ expression was only observed in ovaries, and exclusively in the germ-line, starting at around stage 5-6 of oogenesis, similar to the pattern of accumulation of bcd mRNA (Fig. 1a, St Johnston et al., 1989) . Analysis of a series of progressive deletions, using various restriction sites, positions -1790, -1229, -635, -361 and -37, showed that the same pattern and similar level of transcription of the lacZ reporter gene was retained when all DNA upstream of a Sry d binding site, previously shown to be essential for bcd transcription, (Payre et al., 1994) , was removed (Mex2-Z construct, Fig. 1b and data not shown). Position of this Sry d binding site (designated below as sdbsA) thus defines the 5′ border of the functional bcd promoter. We then tested the effect of a 3′ truncation moving the position of the bcd/lacZ fusion from exon 2 to exon 1, 15 bp downstream of the bcd translation initiation codon (position +202). With this construct (Kex1-Z, Fig. 1c ) expression of LacZ was still only observed in the female germ-line. However, this ovarianspecific expression was much stronger than observed with the reference construct, assayed in parallel (Fig. 1a) , suggesting the existence of cis-regulatory elements in the intron down-regulating the level of bcd expression. The same increase in LacZ expression was observed whether or not DNA upstream of sdbs A was present in the construct (compare Kex1-Z and Mex1-Z, Fig. 1c,d ). The main conclusion at this point was that a 239 bp bcd DNA fragment, between positions −37 and +202, is able to drive expression of the lacZ reporter gene specifically in the nurse cells. Further truncation from the 3′ side would result in deletion of the 5′ bcd untranslated region (UTR). In order to test for the possible existence of cis-regulatory elements within this UTR, we replaced it by the Xenopus beta-globin UTR, previously shown to functionally substitute for the bcd sequence in transgenic rescue experiments (McDonald and Struhl, 1988) , leaving only 49 bp of bcd DNA (position −37 to +12, 49bg-Z construct). This bcd/Xenopus globin 5′- UTR/lacZ reporter gene showed an expression restricted to ovaries although this expression was weak and displayed a peculiar antero-posterior gradient in the nurse-cell chamber not observed with the reference construct (Fig. 1d,e) . In situ hybridization on dissected ovaries from transformant lines using a probe complementary to the 3′ lacZ tag showed that the RNAs transcribed from the 49bg-Z transgene were uniformly distributed in the nurse cell chamber (Fig. 1d′ ,e′, and data not shown). This indicates that the observed gradient of LacZ activity specifically observed with this construct is likely due to translation-regulatory signals in the Xenopus 5′ globin UTR. We therefore can conclude that the 49bp (−37 to +12) fragment of bcd DNA is the primary determinant of bcd specific expression in ovaries. The much weaker level of accumulation of transcripts observed with 49bg-Z, compared to the full-length construct, confirms the presence of an up-regulating cis-element in the bcd 5′-UTR, as previously suggested by McDonald and Struhl (1988) .
Cooperative binding of Sry d homodimers to two sites in the bcd promoter is required for bcd transcription
In our initial study of the control of bcd transcription, we showed the essential role of a single Sry d binding site (sdbs1, renamed below as sdbsA) located between positions −33 and −21 upstream of the bcd transcription start (Payre et al., 1994) . Analysis of the 49 bp proximal bcd promoter region revealed another potential Sry d binding site, denoted below as sdbs B, located between positions −14 and −1, i.e. separated from sdbsA by 7 bp ( Fig. 2A) . In vitro footprinting experiments indicated that sdbsB was a high affinity binding site responsible, together with sdbsA, for the cooperative binding of Sry d to the bcd promoter (Payre et al., 1997) . EMSA analysis (Fig. 2B ) confirmed that either mutation of sdbsA or sdbsB results in a similar decrease of Sry d binding in vitro, typical of the loss of binding cooperation observed when going from two to one Sry d binding sites (sdcs) (Payre et al., 1997) . We therefore tested whether, like sdbsA, sdbsB was required for bcd transcription. Each of these two sites was separately mutated in the context of a bcd transgene (p2107) previously shown to be able to rescue bcd mutations (McDonald et al., 1993, Fig. 2A ). This functional transgene contains a 7.5 kb bcd genomic fragment (Driever and Nüsslein-Volhard, 1988b) , modified by the insertion of a 1.3 kb lacZ RNA tag in the bcd 3′-UTR region. The unmodified and mutated transgenes, p2107, p2107A − and p2107B
− , respectively, were introduced into the fly genome, and transgenic lines established. Using standard genetic crosses, each transgene was then introduced in bcd mutant backgrounds and the cuticles of embryos laid by the bcd transgenic females were examined for anterior patterning defects. For these experiments, we used the bcd E3 allele because of its intermediate phenotype likely to be sensitive to even small changes in the level of expression of the bcd gene transgene. While one copy of p2107 completely rescued the bcd phenotype, neither p2107A − nor p2107B − did significantly improve this phenotype, indicating that both sdbs sites are required for normal levels of bcd activity. Only with two copies of p2107B − , did we observe a slight rescue (Fig. 2C ). To further confirm that the absence of rescue by p2107A − or p2107B − resulted from a lack of bcd transcription, we looked at the accumulation of the corresponding bcd-lacZ transcript in ovaries of otherwise wild-type, transgenic females. Endogenous bcd mRNA level were used as internal standard for quantification of mRNA. Fig. 2D shows that mutation of either sdbsA or sdbsB results in the reduction of bcd transcript accumulation to undetectable levels, demonstrating that both Sry d binding sites present in the proximal bcd promoter region are essential for bcd transcription.
Together with the previous report that Sry d makes homodimers in solution (Payre et al., 1997) , these in vivo results indicated that activation of bcd transcription requires cooperative binding of Sry d homodimers mediated by the two sites present in the proximal promoter region. This requirement could explain by itself the high sensitivity of bcd transcription to sry d mutations that affect either its affinity for DNA or its homodimerization properties (Payre et al., 1997 ). Yet, Sry d is expressed and required in both various types of somatic cells and male and female germ line cells (Payre et al., 1989; Crozatier et al., 1992) whereas bcd transcription only occurs in the female germline. This suggested the possible existence of other transacting factor(s) involved in the regulation of bcd transcription, that had escaped genetic screens. We therefore undertook experiments to (i) identify putative tissue-specific cis-regulatory elements other than sdbs in the 49 bp bcd promoter region and (ii) test whether Sry d binding sites are by themselves able to mediate transcriptional activation of a downstream gene and, if so, whether the bcd promoter context is determinant for the restriction of bcd activation to nurse cells.
The bcd promoter configuration potentiates the ability of Sry d to activate bcd
In addition to sdbsA and sdbsB, the 49bp bcd fragment driving lacZ expression specifically in ovaries contains 12 bp of DNA, downstream of sdbsB, that include two (out of the three) major bcd transcription start sites (Fig. 3A and Seeger and Kaufman, 1990) . We determined whether these 12 bp contained a cis-regulatory element, by mutating nine nucleotide positions, leaving intact the two transcription start sites (Fig. 3A) . The effect of these mutations was tested in the context of a strong bcd promoter configuration, i.e. the Mex1-Z construct, (construct Mex1-Zm12). We could not detect any difference in the pattern of lacZ expression driven by Mex1-Zm12 compared to Mex1-Z transgenes (Fig.  3a,b) , suggesting that the 12 bp nucleotide sequence is not meaningful for the nurse-cell specific activation of bcd transcription. Sry d consensus binding sites are able by themselves to promote a strong transcription of a downstream gene in cultured Drosophila SL2 cells (Payre et al., 1997) . The restriction of bcd activation to nurse cells, contrasting with the ubiquitous expression of Sry d raised the possibilities that either the structure of sdbsA and sdbsB, or the length or sequence of the spacer in between was determinant for this tissue-restriction. We tested the first possibility by placing upstream of a TATA box in the hsp70 minimal promoter, either two sdcs in the same configuration than previously used in cell culture, or the 37 bp bcd DNA fragment containing sdbs A and B (AB-HZ50 construct, Fig. 3B and data not shown). Both constructs gave the same result: the complete absence of expression of the lacZ reporter gene in ovaries. This contrasted with results obtained with the 49 bp bcd DNA fragment, whereas expression was observed in other tissues, the testis and larval CNS in all independent AB-HZ50 lines examined, and additional sites specific to each line (Fig. 3c,d and data not shown). These results led us to conclude that, whereas functional in cultured cells, Sry d binding sites are not sufficient to activate the expression of a reporter gene in all tissues where Sry d is expressed during fly development, and that other specific requirement must be met for the activation of bcd transcription. We then tested whether the length and/or nucleotide sequence of the 7 bp spacer separating sdbsA and sdbsB was determinant, by substituting for a 11 bp spacer of unrelated sequence. The modified bcd transgene remained efficiently transcribed, as assayed by both phenotypic rescue and Northern blot analysis (data not shown), indicating that the structure and exact length of the 7 bp spacer present in wild type bcd is not determinant. The only cis-regulatory elements identified within the 49 bp bcd DNA fragment were therefore sdbs A and B, indicating that the bcd promoter configuration, i.e. the position of sdbs immediately upstream of the bcd transcription start with no intervening TATA box, was decisive for bcd activation in ovarian nurse cells. Although the possibility that sdbs could bind another factor than Sry d cannot be formally excluded, it further suggested the recruitment by Sry d of a co-activator specifically present in these cells.
Converting bcd from a Sry d into a Sry b target
The close paralog of Sry d, Sry b, does not substitute for Sry d in activating bcd (Crozatier et al., 1992) . The Sry b and d DNA consensus recognition sites, sbcs: 5′-TGCGCATCTCTGR-3' and sdcs: 5′-TTYCCATCTC-TAR-3', respectively, differ from each other at 4 out of 13 positions, and these differences are sufficient for discriminatory in vitro binding of Sry b and Sry d to their respective recognition sites (Payre and Vincent, 1991 , and data not shown). We could then ask whether this difference in DNA recognition properties was sufficient to account for the failure of Sry b to activate bcd transcription. We thus replaced both sdbsA and sdbsB by sbcs in the p2107 bcd transgene and assayed for expression of this modified transgene, p2107sbcs (Fig. 4A) , in a wild type or sry d mutant background. Northern blot analysis of RNA from p2107sbcs transgenic females showed the accumulation of bcd-lacZ transcripts in ovaries, to levels similar to those observed with p2107, taking into account variations between individual transformant lines (Fig. 4B and data not shown) . To further verify that the transcription of p2107sbcs was independent of Sry d activity, the p2107 and p2107sbcs transgenes were introduced into a sry d SF2 mutant background. sry d SF2 homozygous escaper females lay eggs, a fraction of which develop to the point of making cuticles (Crozatier et al., 1992) . These cuticles typically show a strong bcd-like phenotype with a deletion of anterior structures and thoracic segments and duplication of the posterior telson (Fig. 4C) . While p2107 even present at two copies did not significantly improve this phenotype, one copy of p2107sbcs restored the development of thoracic and some anterior structures. With two copies of the transgene, a complete rescue was observed, with the cuticles of rescued embryos being indistinguishable from wild type cuticles. We therefore can conclude p2107sbcs is efficiently transcribed in ovaries, independently of Sry d activity. In situ hybridization on dissected ovaries of p[2107sbcs] transgenic females, or embryos laid by such females, indicated that transcription of this modified bcd transgene was restricted to nurse cells (data not shown). Altogether these results indicate that replacing the two binding sites of Sry d by binding sites
Discussion
Cooperative binding of Sry d homodimers to the bcd promoter is required for bcd transcription
Since the initial report of the structure of TFIIIA, a vast number of C2H2 zinc finger transcription factors have been characterized in all eucaryotes (Klug and Schwabe, 1995;  for review). Characteristic of this class of transcription factors is the variable number of fingers per protein, each finger folding into an independent domain capable to specifically interact with DNA. Contrary to other families of zinc finger transcription factors, however, C2H2 proteins display non palindromic recognition sites and are generally thought to bind DNA as monomers (Mackay and Crossley, 1998 ; for review). The involvement of a subset of C2H2 fingers in mediating specific protein-protein interactions has been recently reported as, for example, the related proteins Ikaros and Aiolo, two transcriptional regulators of lymphocyte differentiation that form homo-and heterodimeric complexes (Sun et al., 1996; Morgan et al., 1997) . We have also recently shown that Sry d forms homodimers; in this case, homodimerization requires the sixth C2H2 finger plus an evolutionary conserved non canonical C2C2 zinc finger located at the N-terminus of the protein (Payre et al., 1997) . Homodimer formation is required for Sry d cooperative binding to multiple tandem binding sites and synergistic activation of a reporter gene in transfected cells (Payre et al., 1997) . Variation in the bcd gene dosage has a strong effect on the positioning of morphological and molecular landmarks in the early gastrulating embryo (Driever and Nüsslein-Volhard, 1988b; Struhl et al., 1989 ; review by Driever, 1993; Namba et al., 1997) . The level of bcd transcription reached when either sdbs A or B is mutated, is well below the minimal threshold required for embryo survival. This demonstration that each of the two sdbs in the bcd proximal promoter is required for bcd transcription confirmed, in vivo, the crucial role of Sry d homodimerization.
The bcd promoter context is decisive for nurse-cell specific activation of bcd by Sry d
Successive deletions in the bcd promoter allowed us to localize an enhancer sequence in the 5′-UTR and a downregulating element located downstream of the ATG initiator codon probably in the first intron, and identified a 49 bp minimal promoter region sufficient to drive expression of a reporter gene specifically in nurse cells. Detailed analysis of this 49 bp DNA fragment which includes the two sdbs and bcd transcription starts with no TATA box, failed to reveal any additional cis-regulatory element. We have previously shown that the orientation of scds relative to the direction of transcription strongly influences the level of transactivation in transfected cells: this level is several fold higher in the orientation found in the bcd promoter, compared to the inverse. However, neither two sdcs in the appropriate orientation, nor a 38 bp bcd DNA fragment containing sdbs A and sdbsB, were able by themselves to promote transcription in nurse cells when placed upstream of the TATA-box containing minimal hsp70 promoter. This observation suggested the imposition of topological constraints on the ability of Sry d to activate bcd transcription by the bcd promoter configuration itself. All our data are consistent with a model in which bcd transcription requires the cooperative binding of Sry d homodimers to the tandem sdbs sites and subsequent recruitment of a nurse cell-specific coactivator. What could be the nature of this co-activator? One possibility is a nurse cell-specific TATA binding protein (TBP) associated factor (TAF). TAFS function as requisite 'coactivators' mediating the interaction between sequence-specific-activators and the general transcription machinery, although not generally required, per se, for regulated transcription (Verrijzer and Tjian, 1996; for review) . A role of some TAFs in the specific recognition of promoters that lack a canonical TATA box (and this is the case of bcd) has nevertheless recently been proposed (Hampsey and Reinberg, 1997). Another possibility is the existence of an alternative form of TPB (TATA binding protein), such as TRF expressed in the CNS and male reproductive organs (Crowley et al., 1993; Hansen et al., 1997) , that could function to transduce the effects of activators in establishing the nurse-cell specific transcription program. Further experiments are now needed to distinguish between these possibilities.
Turning bcd from a Sry d into a Sry b target. DNA specific recognition makes it all
The modular structure of the DNA binding domain of C2H2 proteins allows extensive variations in length and sequence of the DNA sites that they specifically recognize and is prone to the emergence of new specificities during evolution. The identification of bcd as a Sry d target provided us with a direct in vivo assay of the role of DNA specific recognition in the functional distinction between the two close paralogs, Sry b and Sry d, which both function as transcription activators in cultured cells (Payre et al., 1997 and data not shown) and are present at high levels in nurse cell nuclei. Replacing Sry d by Sry b binding sites (p2107sbcs construct) restored transcription of a bcd transgene in sry d mutant ovaries, even though the level of transcription of p2107sbcs was lower than that of p2107 in wildtype embryos. Whereas the absence, so far, of sry b specific mutations precludes the unambiguous demonstration that Sry b is the protein which activates transcription of p[2107sbcs], this is likely for several reasons. First, Sry b is the only nuclear protein which specifically binds to sbcs in an EMSA assay (Payre and Vincent, 1991) . Second, like Sry d, it binds cooperatively to multiple sites, leading to synergistic transactivation of a reporter gene (P. Buono, unpublished data). Third, a chimaeric protein in which the entire N-terminal region of Sry d has been replaced by the analogous region of Sry b binds cooperatively to sdcs and is able to substitute for Sry d in activating bcd expression (Noselli et al., 1992; Crozatier et al., in preparation) , suggesting that the structural divergence between the two proteins in their N-terminus does not prevent interaction with (a) ternary factor(s) at the bcd promoter. We conclude from the sdcs into sbcs substitution experiment that the main driver of functional diversification of Sry b and Sry d was the divergence in their DNA-specific recognition properties. This divergence resulted in the regulation of transcription of separate genes and, as shown here with bcd, the control of different developmental programs.
Experimental procedures
Fly strains
The sry d EMS induced allele sry d SF2 was described in Crozatier et al., 1992 . The bcd E3 mutant strain was obtained from the Tübingen stock Center (Tearle and Nüsslein-Volhard, 1987) . The ry 506 strain was used as wild type strain for injection of the p[AB-HZ50 ry + ] construct. All the other constructs were injected into a w − strain which was also used for control RNA preparations. Flies were grown under standard conditions at 22°C and eggs processed for the determination of the cuticular phenotypes as described (Wieschaus and Nüsslein-Volhard, 1986 ).
RNA and EMSA analysis
RNA preparation from ovaries, Northern blot analysis, whole-mount in situ hybridization and X-Gal staining were as in Payre et al. (1989) , Payre et al. (1994) . Expression in E. coli and purification of the recombinant Sry d protein and electrophoretic mobility shift assays (EMSA) were as described in Payre et al. (1997) .
Reporter gene constructs and transgenic lines
AB-HZ50 was constructed by inserting a 37 bp bcd DNA fragment upstream of the hsp70 TATA box in the HZ50PL plasmid (Hiromi and Gehring, 1987) . The p2107 construct is a w + P-vector which contains 7.5 kbp of bcd genomic from a Kpn I site, position −2725, to an EcoRI site, position +4594, i.e. the entire bcd coding region and 3′-UTR, with a 1.3 kb lacZ RNA tag inserted in the 3′-UTR (McDonald et al., 1993) . The Kex2-Z construct contains 3648 bp of bcd DNA, from the Kpn I site to an EcoRI site, position +923, introduced in the second exon by site directed mutagenesis. This DNA fragment was fused in frame to the E coli betagalactosidase coding region. Mex2-Z was generated from Kex2-Z by removing upstream DNA, from the Kpn I site to a Mun I site, position −37. Kex1-Z and Mex1-Z are Kex2-Z and Mex2-Z derivates, respectively, with the bcd-lacZ fusion in exon 1, five amino-acids downstream of the bcd ATG, at a EcoRI site, position +202. Mex1-Z-m12 was generated from Mex1-Z by mutating 8 out of the 12 bp of bcd DNA downstream of sdbsB that are included in this construct. The 49bgZ construct contains 49 bp of bcd DNA (Positions −37; +12) fused to the 5′-UTR of the Xenopus beta globin gene placed upstream of the lacZ coding sequence. For site specific mutagenesis of sdbsA and sdbsB, we subcloned the 1.8 kb BamHI/PstI (−1790, +12) bcd fragment in pTZ18R (Pharmacia) and used the procedure of Kunkel (1985) . Sequences of the oligonucleotides used to mutate sdbsA, sdbsB and replace sdbs by sbcs are, respectively:
A − 5′-CAATTGTGCCATGGGTACATCTCTTCGC-3′ B − 5′-CATCTCTTCGCCCATGGGAAAATAACGGC-3′ sbcs 5′-CGCCAATTTGCGCATCTCTGAATCTCTTTG
CGCATCTCTGAATAACGGC-3′
The A − and B − oligonucleotides incorporated a NcoI restriction site (underlined) to facilitate mutant identifica-tion. The specific nature of the introduced mutations was then confirmed by sequencing. After introduction of these mutations, the BamHI/PstI fragment was placed back into p[2107] for fly transformation (Rubin and Spradling, 1982) .
